CJC-1295 (No DAC) 10 mg
Advanced Growth Hormone-Releasing Hormone (GHRH) Research
Unlike the DAC-modified version, CJC-1295 (No DAC) is a shorter-acting GHRH analog designed to more closely mimic the body’s natural pulsatile release of growth hormone. It has become a widely studied peptide in research involving the growth hormone/IGF-1 axis, metabolism, tissue regeneration, recovery, and healthy aging models. Its pharmacokinetic profile also makes it a common research partner with growth hormone secretagogues such as Ipamorelin.
Manufactured to rigorous quality standards and supported by comprehensive third-party analytical testing, our CJC-1295 (No DAC) delivers exceptional purity, identity, and batch-to-batch consistency for reliable laboratory research.
Key Research Areas
- Growth Hormone-Releasing Hormone (GHRH) signalling
- Pulsatile growth hormone (GH) secretion
- Growth hormone (GH) and IGF-1 axis research
- Endocrine physiology
- Tissue repair and regeneration models
- Exercise recovery and muscle physiology
- Healthy aging and metabolic research
Product Features
- 10 mg CJC-1295 (No DAC) per vial
- High-purity lyophilized peptide
- Manufactured under strict quality standards
- Third-party tested for identity and purity
- Certificate of Analysis (COA) available for every batch
- Intended exclusively for laboratory research use
